S Bank Fund Management LTD Alnylam Pharmaceuticals, Inc. Transaction History
S Bank Fund Management LTD
- $531 Billion
- Q1 2025
A detailed history of S Bank Fund Management LTD transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, S Bank Fund Management LTD holds 1,760 shares of ALNY stock, worth $475,534. This represents 0.09% of its overall portfolio holdings.
Number of Shares
1,760Holding current value
$475,534% of portfolio
0.09%Shares
1 transactions
Others Institutions Holding ALNY
# of Institutions
684Shares Held
110MCall Options Held
863KPut Options Held
759K-
Capital World Investors Los Angeles, CA16.7MShares$4.53 Billion0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$3.53 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.58 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.15MShares$1.93 Billion0.44% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.38MShares$1.18 Billion0.64% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $33.2B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...